Astral Limited (NSE:ASTRAL)
India
· Delayed Price · Currency is INR | Market Cap | 412.38B |
| Revenue (ttm) | 61.62B |
| Net Income (ttm) | 5.03B |
| Shares Out | 268.65M |
| EPS (ttm) | 18.73 |
| PE Ratio | 81.95 |
| Forward PE | 60.42 |
| Dividend | 3.75 (0.24%) |
| Ex-Dividend Date | Nov 11, 2025 |
| Volume | 468,118 |
| Average Volume | 968,007 |
| Open | 1,545.50 |
| Previous Close | 1,535.00 |
| Day's Range | 1,532.00 - 1,558.90 |
| 52-Week Range | 1,250.00 - 1,768.70 |
| Beta | 0.21 |
| RSI | 44.07 |
| Earnings Date | Feb 5, 2026 |
About Astral
Astral Limited engages in the manufacture and marketing of pipes and fittings, water tanks, and adhesives and sealants in India and internationally. It operates in two segments, Plumbing, and Paints and Adhesives. It offers plumbing pipes and fittings, sewerage and drainage pipes and fittings, agriculture pipes and fittings, cable protection system, industrial piping system, fire protection system, urban infrastructure, ancillary products, and column pipe; and roto moulding, blow moulded, loft, and anti-viral copper shield water tanks. It also ... [Read more]
Financial Performance
In fiscal year 2025, Astral's revenue was 58.32 billion, an increase of 3.39% compared to the previous year's 56.41 billion. Earnings were 5.24 billion, a decrease of -4.08%.
Financial StatementsNews
Astral Transcript: Q3 25/26
Q3 FY26 saw 17% volume growth and 18.2% EBITDA margin, with revenue up 10% YoY. New plants and product lines drove market share gains, while CapEx investments began yielding results. Guidance remains for double-digit growth and strong margins, with new CPVC capacity set to boost future performance.
Astral Earnings Call Transcript: Q2 2026
Q2 FY2026 saw 20% volume and 15% value growth, with EBITDA margin above 15-16% guidance despite industry headwinds. New plants and product diversification drove market share gains, while adhesives, bathware, and paint segments posted strong growth. Full-year double-digit growth guidance is reaffirmed.
Astral Earnings Call Transcript: Q1 2026
Q1 FY26 saw flat pipe volumes and margin pressure from inventory losses, but strong growth in Bathware, Paints, and Adhesives. Major backward integration with a new CPVC resin plant is expected to boost margins and working capital efficiency. Double-digit growth is guided for FY26.
Astral Transcript: Q4 24/25
Despite a challenging year with volatile PVC prices and industry headwinds, strong growth in value-added products, adhesives, and bathware supported healthy margins. Strategic expansions, new product launches, and a robust CapEx pipeline position the company for double-digit growth as market conditions normalize.
Astral Transcript: Q3 24/25
Q3 saw 2% revenue and 9.3% EBITDA growth YoY, with strong margins in pipes, adhesives, and bathware despite industry headwinds. Guidance remains for 10–15% volume growth next year, with CapEx tapering and new product launches supporting future expansion.
Astral Transcript: Q2 24/25
Q2 FY25 saw stable margins despite a challenging environment with PVC price volatility and subdued demand. Growth in bathware and adhesives offset flat overall revenue, while expansion and new product launches position the company for improved performance in H2.
Astral Transcript: Q1 24/25
Q1 FY25 saw 16% volume growth and 8% revenue growth, with gross margins above 40% despite high polymer price volatility and one-time branding costs. New plant expansions, product launches, and strong performance in adhesives and bathware support a positive full-year outlook.